ZA873338B - Process for isolating and purifying p. falciparium cs protein vaccine expressed in recombinant e. coli - Google Patents
Process for isolating and purifying p. falciparium cs protein vaccine expressed in recombinant e. coliInfo
- Publication number
- ZA873338B ZA873338B ZA873338A ZA873338A ZA873338B ZA 873338 B ZA873338 B ZA 873338B ZA 873338 A ZA873338 A ZA 873338A ZA 873338 A ZA873338 A ZA 873338A ZA 873338 B ZA873338 B ZA 873338B
- Authority
- ZA
- South Africa
- Prior art keywords
- falciparium
- coli
- recombinant
- purifying
- isolating
- Prior art date
Links
- 241000588724 Escherichia coli Species 0.000 title 1
- 229940023143 protein vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86181086A | 1986-05-12 | 1986-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA873338B true ZA873338B (en) | 1988-07-27 |
Family
ID=25336830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA873338A ZA873338B (en) | 1986-05-12 | 1987-05-11 | Process for isolating and purifying p. falciparium cs protein vaccine expressed in recombinant e. coli |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0252588A3 (de) |
JP (1) | JPH01502556A (de) |
AU (1) | AU603586B2 (de) |
DK (1) | DK10288D0 (de) |
FI (1) | FI885237A0 (de) |
PT (1) | PT84850B (de) |
WO (1) | WO1987006939A1 (de) |
ZA (1) | ZA873338B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0289129A3 (de) * | 1987-03-26 | 1990-10-10 | Repligen Corporation | Herstellung von hochgereinigtem Protein A |
IL85905A0 (en) * | 1987-03-30 | 1988-09-30 | Univ New York | Immunogenic recombinant yeast expression product and method for purifying it |
US6093406A (en) * | 1988-06-02 | 2000-07-25 | The United States Of America As Represented By The Secretary Of The Army | Vaccine for induction of immunity to malaria |
US5231168A (en) * | 1988-09-16 | 1993-07-27 | Statens Seruminstitut | Malaria antigen |
JPH0687974B2 (ja) * | 1990-03-27 | 1994-11-09 | 忠一 平山 | 発熱物質の吸着材料 |
DE69124561T2 (de) * | 1990-03-30 | 1997-09-04 | Shiseido Co Ltd | Methode zur reinigung von polypeptiden |
EP1539798B1 (de) | 2002-09-06 | 2010-11-24 | Genentech, Inc. | Verfahren zur proteinextraktion |
CA2557686C (en) * | 2004-04-02 | 2012-06-05 | F. Hoffmann-La Roche Ag | Highly purified proteinase k |
US20100273983A1 (en) * | 2007-04-05 | 2010-10-28 | The University Of Queensland | Method of purifying peptides by selective precipitation |
WO2012154199A1 (en) * | 2010-10-18 | 2012-11-15 | The Government Of The United States, As Represented By The Secretary Of The Army | Soluble recombinant plasmodium falciparum circumsporozoite protein |
US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
JP7262449B2 (ja) * | 2017-05-15 | 2023-04-21 | シー‐レクタ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 酵素産物 |
CN114630584A (zh) * | 2019-11-07 | 2022-06-14 | 纽崔西亚公司 | 具有致耐受性肽的深度乳清蛋白水解产物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4342832A (en) * | 1979-07-05 | 1982-08-03 | Genentech, Inc. | Method of constructing a replicable cloning vehicle having quasi-synthetic genes |
IL74409A (en) * | 1984-02-22 | 1994-08-26 | Wellcome Found | Cloning of the p195 gene of p. falciparum and fragments thereof |
ZA855232B (en) * | 1984-07-23 | 1986-02-26 | Univ New York | Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein |
CN86100979A (zh) * | 1985-02-07 | 1986-12-17 | 史密丝克莱恩贝克曼公司 | 疟疾疫苗的制备方法 |
AU5293486A (en) * | 1985-02-07 | 1986-08-14 | Smithkline Beckman Corporation | Malaria vaccine against plasmodium falciparum |
-
1987
- 1987-05-08 EP EP87304133A patent/EP0252588A3/de not_active Ceased
- 1987-05-11 PT PT84850A patent/PT84850B/pt unknown
- 1987-05-11 JP JP62503190A patent/JPH01502556A/ja active Pending
- 1987-05-11 ZA ZA873338A patent/ZA873338B/xx unknown
- 1987-05-11 AU AU74400/87A patent/AU603586B2/en not_active Ceased
- 1987-05-11 WO PCT/US1987/001115 patent/WO1987006939A1/en active Application Filing
-
1988
- 1988-01-11 DK DK010288A patent/DK10288D0/da not_active Application Discontinuation
- 1988-11-11 FI FI885237A patent/FI885237A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI885237A (fi) | 1988-11-11 |
WO1987006939A1 (en) | 1987-11-19 |
AU603586B2 (en) | 1990-11-22 |
DK10288A (da) | 1988-01-11 |
JPH01502556A (ja) | 1989-09-07 |
PT84850A (en) | 1987-06-01 |
EP0252588A2 (de) | 1988-01-13 |
FI885237A0 (fi) | 1988-11-11 |
EP0252588A3 (de) | 1989-07-12 |
PT84850B (pt) | 1990-02-08 |
DK10288D0 (da) | 1988-01-11 |
AU7440087A (en) | 1987-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8721424D0 (en) | Recombinant expression method | |
AU2964489A (en) | Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides | |
EP0293394A4 (de) | Neue thrombolytische proteine. | |
IL81839A0 (en) | Polypeptide,dna and its use | |
ZA873338B (en) | Process for isolating and purifying p. falciparium cs protein vaccine expressed in recombinant e. coli | |
GB8719963D0 (en) | Recombinant dna products | |
EP0209543A4 (de) | Peptidfragmente menschlicher apolipoproteine, typspezifische antikörper und verwendungsverfahren. | |
EP0264819A3 (en) | Variant aequorin genes and process for producing variant aequorin proteins | |
PT85461A (en) | Process for preparing recombinant htlv-iii proteins and uses thereof | |
PT85538A (en) | Process for preparing homogeneous recombinant immune interferon fragments | |
NZ233672A (en) | Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence | |
IL85905A0 (en) | Immunogenic recombinant yeast expression product and method for purifying it | |
EP0242359A4 (de) | Klonierungsträger zum klonieren eines grossen dns-fragmentes und impfstoff enthaltend 987p fimrialprotein. | |
IL85239A0 (en) | Recombinant alveolar surfactant protein,its production and purification and pharmaceutical compositions containing it | |
PT86162A (en) | Recombinant protein expression | |
IE871212L (en) | "process for isolating and purifying p. falciparum cs¹protein vaccine expressed in recombinant e. colt" | |
AU571460B2 (en) | Alpha interferon dna, recombinant plasmid, engineered organism and alpha interferon polypeptide | |
EP0288901A3 (en) | Recombinant human glutathione peroxidase, process for preparing the same and dna coding the same | |
KR880009039A (ko) | 재조합 α-인터페론의 정제방법 | |
GB8623925D0 (en) | Recombinant dna methods | |
GB8729970D0 (en) | Recombinant dna for use in yeast | |
IE873131L (en) | Recombinant protein expression. | |
GB8728975D0 (en) | Purification of recombinant protein | |
GB8631071D0 (en) | Recombinant dna | |
IE870674L (en) | Polypeptide, dna and its use |